Genetic association of TLR4 Asp299Gly, TLR4 Thr399Ile, and CD14 C-159T polymorphisms with the risk of severe RSV infection: A meta-analysis

Influenza and other Respiratory Viruses

Volumn 10, Issue 3, 2016, Pages 224-233

  Zhou, Jiahui ^a,b   Zhang, Xiangning ^a,b   Liu, Shuming ^a,b   Wang, Ziyou ^a,b   Chen, Qicong ^c   Wu, Yongfu ^a   He, Zhiwei ^a,b   Huang, Zunnan ^a,b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b Key Laboratory for Medical Molecular Diagnostics of Guangdong Province   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Asp299Gly; C 159T; CD14; Meta analysis; Polymorphisms; RSV infection; Thr399Ile; TLR4

Indexed keywords

CD14 ANTIGEN; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, HUMAN;

ALLELE; BOVINE RESPIRATORY SYNCYTIAL VIRUS INFECTION; BRONCHIOLITIS; DISEASE SEVERITY; ETHNICITY; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INFECTION RISK; INNATE IMMUNITY; NONHUMAN; POPULATION DISTRIBUTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; CASE CONTROL STUDY; CHINA; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; META ANALYSIS; ODDS RATIO; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; VIROLOGY;

ANTIGENS, CD14; BRONCHIOLITIS; CASE-CONTROL STUDIES; CHINA; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TOLL-LIKE RECEPTOR 4;

EID: 84960154750     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12378     Document Type: Review

References (35)

1. Ciencewicki JM, Wang X, Marzec J et al. A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection. FASEB J 2014; 28:1947-1956.
2. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140:543-546.
3. Broadbent L, Groves H, Shields MD, Power UF. Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials. Influenza Other Respir Viruses 2015; 9:169-178.
4. Kaan PM, Hegele RG. Interaction between respiratory syncytial virus and particulate matter in guinea pig alveolar macrophages. Am J Respir Cell Mol Biol 2003; 28:697-704.
5. Bradley JP, Bacharier LB, Bonfiglio J et al. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 2005; 115:e7-e14.
6. Lanari M, Giovannini M, Giuffre L et al. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity. Pediatr Pulmonol 2002; 33:458-465.
7. Stark JM, McDowell SA, Koenigsknecht V et al. Genetic susceptibility to respiratory syncytial virus infection in inbred mice. J Med Virol 2002; 67:92-100.
8. Goetghebuer T, Kwiatkowski D, Thomson A, Hull J. Familial susceptibility to severe respiratory infection in early life. Pediatr Pulmonol 2004; 38:321-328.
9. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 2001; 75:10730-10737.
10. Ikejima K, Enomoto N, Seabra V, Ikejima A, Brenner DA, Thurman RG. Pronase destroys the lipopolysaccharide receptor CD14 on Kupffer cells. Am J Physiol 1999; 276:G591-G598.
11. Di Gioia M, Zanoni I. Toll-like receptor co-receptors as master regulators of the immune response. Mol Immunol 2015; 63:143-152.
12. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLoS Med 2009; 6:e1000100.
13. Sagoo GS, Little J, Higgins JP. Systematic reviews of genetic association studies. Human genome epidemiology network. PLoS Med 2009; 6:e28.
14. Higgins JPT GS. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration. Available at http://www.cochrane-handbook.org (Accessed Dec 8 2015).
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560.
16. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539-1558.
17. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50:1088-1101.
18. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25:603-605.
19. Wells GA, Shea B, O'Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available at http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm (Accessed Dec 8 2015).
20. Goutaki M, Haidopoulou K, Pappa S et al. The role of TLR4 and CD14 polymorphisms in the pathogenesis of respiratory syncytial virus bronchiolitis in greek infants. Int J Immunopathol Pharmacol 2014; 27:563-572.
21. Paulus SC, Hirschfeld AF, Victor RE, Brunstein J, Thomas E, Turvey SE. Common human Toll-like receptor 4 polymorphisms-role in susceptibility to respiratory syncytial virus infection and functional immunological relevance. Clin Immunol 2007; 123:252-257.
22. Puthothu B, Forster J, Heinzmann A, Krueger M. TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease. Dis Markers 2006; 22:303-308.
23. Helminen M, Nuolivirta K, Virta M et al. IL-10 gene polymorphism at -1082 A/G is associated with severe rhinovirus bronchiolitis in infants. Pediatr Pulmonol 2008; 43:391-395.
24. Lofgren J, Marttila R, Renko M, Ramet M, Hallman M. Toll-like receptor 4 Asp299Gly polymorphism in respiratory syncytial virus epidemics. Pediatr Pulmonol 2010; 45:687-692.
25. Kresfelder TL, Janssen R, Bont L, Pretorius M, Venter M. Confirmation of an association between single nucleotide polymorphisms in the VDR gene with respiratory syncytial virus related disease in South African children. J Med Virol 2011; 83:1834-1840.
26. Tal G, Mandelberg A, Dalal I et al. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 2004; 189:2057-2063.
27. Inoue Y, Shimojo N, Suzuki Y et al. CD14 -550 C/T, which is related to the serum level of soluble CD14, is associated with the development of respiratory syncytial virus bronchiolitis in the Japanese population. J Infect Dis 2007; 195:1618-1624.
28. Jung YH, Seo JH, Kim HY et al. The relationship between asthma and bronchiolitis is modified by TLR4, CD14, and IL-13 polymorphisms. Pediatr Pulmonol 2015; 50:8-16.
29. Zhang YN, Li YJ, Li H, Zhou H, Shao XJ. Association of CD14 C159T polymorphism with atopic asthma susceptibility in children from Southeastern China: a case-control study. Genet Mol Res 2015; 14:4311-4317.
30. Wang J, Simayi M, Wushouer Q et al. Association between polymorphisms in ADAM33, CD14, and TLR4 with asthma in the Uygur population in China. Genet Mol Res 2014; 13:4680-4690.
31. Sahin F, Yildiz P, Kuskucu A, Kuskucu MA, Karaca N, Midilli K. The effect of CD14 and TLR4 gene polymorphisms on asthma phenotypes in adult Turkish asthma patients: a genetic study. BMC Pulm Med 2014; 14:20.
32. Wu SQ, Zhang KB, Chen HQ, Zhao ZG, Wang GL, Chen C. Association between gene polymorphism of CD14-159 (C/T) and allergic asthma. Mol Med Rep 2011; 4:1127-1130.
33. Wang G, Deval J, Hong J et al. Discovery of 4'-chloromethyl-2'-deoxy-3', 5'-di-O-isobutyryl-2'-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection. J Med Chem 2015; 58:1862-1878.
34. Boyoglu-Barnum S, Todd SO, Chirkova T et al. An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice. Virology 2015; 483:117-125.
35. Wainwright C. Acute viral bronchiolitis in children- a very common condition with few therapeutic options. Paediatric respiratory reviews. 2010;11:39-45.